Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis

被引:51
|
作者
Liu, CG
Sleat, DE
Donnelly, RJ
Lobel, P [1 ]
机构
[1] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Lab Med & Pathol, Mol Biocore Facil, Newark, NJ 07103 USA
关键词
D O I
10.1006/geno.1998.5328
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mutations in the CLN2 gene result in classical late infantile neuronal ceroid Iipofuscinosis (LINCL), a fatal childhood neurodegenerative disease. In this report, we present the complete sequence of the human CLN2 gene and define its physical relationship with two other genes that have been previously mapped to chromosome 11p15. The CLN2 gene consists of 13 exons and 12 introns and spans 6.65 kh. By SP mapping and primer extension, the 5'-terminus of the CLN2 mRNA was mapped to 32 nucleotides upstream of the proposed initiation codon. A number of other elements were found to be located in close proximity to CLN2, including the gene encoding transcription factor TAF(II)30, the gene encoding intregrin-linked kinase, and an similar to 914-bp fragment that is 82% identical to antithrombin III. In addition, an EST cDNA clone that is transcribed on the strand opposite to CLN2 and that overlaps a portion of the CLN2 gene was-identified. Finally, a set of primer pairs are presented for the amplification of the coding sequences, putative promoter, and splice junctions of the CLN2 gene. Taken together, this information will facilitate the molecular analysis of and genetic testing for classical LINCL. (C) 1998 Academic Press.
引用
收藏
页码:206 / 212
页数:7
相关论文
共 50 条
  • [31] Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis
    Ezaki, J
    Takeda-Ezaki, M
    Oda, K
    Kominami, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (03) : 904 - 908
  • [32] Characterization and chromosomal mapping of a mouse ortholog of the late-infantile ceroid-lipofuscinosis gene CLN2
    Katz, ML
    Liu, PC
    Grob-Nunn, SE
    Shibuya, H
    Johnson, GS
    MAMMALIAN GENOME, 1999, 10 (11) : 1050 - 1053
  • [33] Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
    Dyke, J. P.
    Sondhi, D.
    Voss, H. U.
    Yohay, K.
    Hollmann, C.
    Mancenido, D.
    Kaminsky, S. M.
    Heier, L. A.
    Rudser, K. D.
    Kosofsky, B.
    Casey, B. J.
    Crystal, R. G.
    Balton, D.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (06) : 1160 - 1169
  • [34] Characterizing expressive language skills in children with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2): The caregiver perspective
    Phillips, Dawn
    Fernandez, Vivian
    Nevoret, Marie-Laure
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S86 - S86
  • [35] Variant Late Infantile Neuronal Ceroid Lipofuscinosis (CLN6 Gene) in Saudi Arabia
    Al-Muhaizea, Mohammad A.
    Al-Hassnan, Zuhair N.
    Chedrawi, Aziza
    PEDIATRIC NEUROLOGY, 2009, 41 (01) : 74 - 76
  • [36] Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis
    Lin, L
    Lobel, P
    BIOCHEMICAL JOURNAL, 2001, 357 (357) : 49 - 55
  • [37] Refined mapping of CLN6, the gene for a variant late infantile neuronal ceroid lipofuscinosis
    Sharp, J
    Wheeler, RB
    Lake, BD
    Fox, M
    Gardiner, RM
    Williams, RE
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 129 - 129
  • [38] A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase
    Ezaki, J
    Tanida, I
    Kanehagi, N
    Kominami, E
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) : 2573 - 2582
  • [39] Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)
    Miriam Sindelar
    Jonathan P. Dyke
    Ruba S. Deeb
    Dolan Sondhi
    Stephen M. Kaminsky
    Barry E. Kosofsky
    Douglas J. Ballon
    Ronald G. Crystal
    Steven S. Gross
    Scientific Reports, 8
  • [40] Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)
    Sindelar, Miriam
    Dyke, Jonathan P.
    Deeb, Ruba S.
    Sondhi, Dolan
    Kaminsky, Stephen M.
    Kosofsky, Barry E.
    Ballon, Douglas J.
    Crystal, Ronald G.
    Gross, Steven S.
    SCIENTIFIC REPORTS, 2018, 8